These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34952168)

  • 1. Chronic graft-versus-host disease presenting as acute polymyositis: A case series and systematic review.
    Shahzad M; Chaudhary SG; Basit A; Thellman C; Rodriguez L; Abhyankar SH; McGuirk JP; Mushtaq MU
    Transpl Immunol; 2022 Feb; 70():101520. PubMed ID: 34952168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic graft-versus-host disease-related polymyositis and myocarditis: A case report and review of the literature.
    Yan M; Su F; Cheng F; Shi J; Zheng W; Luo Y; Wang J; Lu H; Zhou H; Huang H; Tan Y
    Transpl Immunol; 2022 Jun; 72():101598. PubMed ID: 35381344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
    Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
    Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
    Wu H; Shi J; Luo Y; Tan Y; Zhang M; Lai X; Yu J; Liu L; Fu H; Huang H; Zhao Y
    JAMA Netw Open; 2021 Jan; 4(1):e2034750. PubMed ID: 33502484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease.
    Wang D; Liu Y; Lai X; Chen J; Cheng Q; Ma X; Lin Z; Wu D; Xu Y
    Front Immunol; 2021; 12():673636. PubMed ID: 34276662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ruxolitinib on the oral mucosa of patients with steroid-refractory chronic Graft-versus-Host disease and oral involvement.
    Kaurinovic M; Delli K; Jonk AE; Biswana A; Hazenberg CLE; Choi G; de Groot MR; Morsink LM; Vissink A; Bellido M
    Clin Oral Investig; 2022 May; 26(5):4209-4216. PubMed ID: 35169886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruxolitinib in the management of steroid-resistant/-dependent acute and chronic graft-versus-host disease: results of routine practice in an academic centre.
    Leung GMK; Sim JPY; Hwang YY; Chan TSY; Lie AKW; Tse E; Kwong YL
    Ann Hematol; 2022 Jan; 101(1):155-163. PubMed ID: 34767056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruxolitinib for the treatment of steroid refractory pediatric chronic graft-versus-host disease.
    Belina ME; Driscoll TA; Blanchard SK; Cardones AR
    Pediatr Dermatol; 2022 May; 39(3):432-433. PubMed ID: 35234308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectacular and Prompt Response to Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.
    Spałek A; Grygoruk-Wiśniowska I; Gruenpeter K; Panz-Klapuch M; Helbig G
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.
    Couriel DR; Beguelin GZ; Giralt S; De Lima M; Hosing C; Kharfan-Dabaja MA; Anagnostopoulos A; Champlin R
    Bone Marrow Transplant; 2002 Oct; 30(8):543-6. PubMed ID: 12379897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
    Kattner AS; Holler E; Holler B; Klobuch S; Weber D; Martinovic D; Edinger M; Herr W; Wolff D
    Ann Hematol; 2020 Apr; 99(4):847-853. PubMed ID: 32086584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of ruxolitinib for steroid-refractory graft-versus-host disease: Systematic review and meta-analysis of randomised and non-randomised studies.
    Zhang MY; Zhao P; Zhang Y; Wang JS
    PLoS One; 2022; 17(7):e0271979. PubMed ID: 35905125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
    Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ruxolitinib Treatment of Steroid-Refractory Graft-versus-Host Disease in Children: A Case Series and Review of the Literature.
    Yan WL; Zhao FY; Gu ME; Liu N; Guo XP; Xu XJ
    Paediatr Drugs; 2023 Sep; 25(5):577-584. PubMed ID: 37284944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].
    Elad S; Levitt M; M Y S
    Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Musculoskeletal Chronic Graft versus Host Disease-A Rare Complication to Allogeneic Hematopoietic Stem Cell Transplant: A Case-Based Report and Review of the Literature.
    Kvinge AD; Kvammen T; Miletic H; Bindoff LA; Reikvam H
    Curr Oncol; 2022 Nov; 29(11):8415-8430. PubMed ID: 36354723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical characteristics of polyserositis as main presentation of chronic graft-versus-host rejection disease after allogeneic hematopoietic stem cell transplantation].
    Wang Q; Li Y; Qiu Z; Xu W; Sun Y; Wang L; Wang M; Liu W; Dong Y; Ou J; Wang W; Liang Z; Wang Q; Cen X; Ren H
    Zhonghua Nei Ke Za Zhi; 2014 May; 53(5):394-7. PubMed ID: 25146408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case report and literature review of chronic graft-versus-host disease manifesting as polymyositis.
    Michelis FV; Bril V; Lipton JH
    Int J Hematol; 2015 Jul; 102(1):144-6. PubMed ID: 25732066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapsing polymyositis in chronic graft versus host disease.
    Sharaf N; Prayson RA
    J Clin Neurosci; 2014 Nov; 21(11):1964-5. PubMed ID: 24980629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex Vivo CD34
    Barba P; Hilden P; Devlin SM; Maloy M; Dierov D; Nieves J; Garrett MD; Sogani J; Cho C; Barker JN; Kernan NA; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Prockop S; Sauter C; Tamari R; van den Brink MR; Avecilla ST; Meagher R; O'Reilly RJ; Goldberg JD; Young JW; Giralt S; Perales MA; Ponce DM
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):452-458. PubMed ID: 28017734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.